Corvia Medical closes $55 million funding round to complete confirmatory trial and pursue FDA approval of Corvia Atrial Shunt
Existing investors provide funding to finish international RESPONDER-HF trial TEWKSBURY, Mass., June 17, 2025 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced the successful closure of a $55 million funding round from the company's existing investment syndicate of Third Rock Ventures, General Catalyst Partners, AccelMed,...
Clover Initiates Phase I Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates
-- Potential First-in-Class Respiratory Combination Vaccine Candidates SCB-1022 (RSV + hMPV) and SCB-1033 (RSV + hMPV + PIV3) Enter the Clinical Trial Stage -- SHANGHAI, June 17, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world, today announced that...
International Pharmaceuticals, Inc. Partners with Anchanto to Power E-commerce Operations in the Philippines
CEBU CITY, Philippines, June 17, 2025 /PRNewswire/ -- Anchanto, the leading global B2B SaaS technology company in e-commerce and supply chain, announced its latest partnership with International Pharmaceuticals, Inc. (IPI), one of Philippines' leading manufacturer and distributor of pharmaceutical and consumer products. Anchanto and IPI mark the start of their partnership during the official signing ceremony...
HIMSS and Informa Markets Partner to Accelerate Digital Health Transformation with Co-Located Conferences in Malaysia for International Healthcare Week
KUALA LUMPUR, Malaysia, June 17, 2025 /PRNewswire/ -- The Healthcare Information and Management Systems Society (HIMSS) has partnered with Informa Markets to co-locate the 2025 HIMSS APAC Health Conference within International Healthcare Week (IHW) 2025, Southeast Asia's premier healthcare event, to be held from July 16 to 18 at the Malaysia International...
Introducing the TELUS Mental Health Index: Nearly half of employees in South Korea experiencing feelings of depression and anxiety, impacting workplace productivity
More than one in three workers in South Korea have no emergency savings; women's mental health lags and more than two in five feel isolated SEOUL, South Korea, June 17, 2025 /PRNewswire/ -- Today, TELUS Health, a globally-recognized leader in workplace wellbeing, introduced its TELUS Mental Health Index ("the Index") to South Korea. Released quarterly, the...
TELUS Mental Health Index: Significant savings gaps and gender disparities challenge the wellbeing of New Zealand’s workforce
TELUS Health Logo (CNW Group/TELUS Health) Two in five workers report no emergency savings, while youth mental health tops parents' concerns, impacting their own wellbeing AUCKLAND, New Zealand, June 17, 2025 /PRNewswire/ -- Today, TELUS Health released its TELUS Mental Health Index ("the Index"), revealing significant savings...
CodeSteri Launches PlaDeo: The World’s First Bio-Plasma Powered Deodorant Device
A Breakthrough in Underarm Odor Control and Axillary Bromhidrosis Treatment SEOUL, South Korea, June 17, 2025 /PRNewswire/ -- CodeSteri Inc., a tech-driven startup based at the Hanyang University College of Medicine in Seoul, today announced the launch of PlaDeo, the world's first electronic deodorant device powered by bio-plasma. Designed to eliminate underarm odor safely and effectively, PlaDeo offers a revolutionary...
HELP Therapeutics and China Resources Sanjiu Announce Strategic Partnership to Co-Develop and Commercialize HiCM-188 for Advanced Heart Failure in Mainland China
NANJING, China, June 16, 2025 /PRNewswire/ -- HELP Therapeutics, a global leader in regenerative medicine, and China Resources Sanjiu Pharmaceutical Company, one of China's largest pharmaceutical companies, have announced a strategic partnership to co-develop and commercialize the investigational cell therapy HiCM-188 in Mainland China. HiCM-188 is the world's first iPSC-derived regenerative therapy for advanced heart failure to receive IND clearance...
Global Action to End Smoking Welcomes Nataliia Toropova as Chief Development Officer
Toropova brings decades of experience in international public health and tobacco harm reduction to Global Action's team of experts committed to funding work to end the smoking epidemic. NEW YORK, June 16, 2025 /PRNewswire/ -- Global Action to End Smoking is pleased to announce the appointment of Nataliia "Natasha" Toropova as its...
A Decade of Persistent Steps, Aspiring for a Thousand Miles: Qyuns’ Grand 10th Anniversary Celebration Held Successfully
TAIZHOU, China, June 16, 2025 /PRNewswire/ -- A Decade of Persistent Steps, Aspiring for a Thousand Miles! From June 13th to 14th, 2025, Qyuns' 10th Anniversary Celebration was successfully held in Taizhou. All employees of Qyuns, along with representatives from research institutions, industry partners, and investment firms, gathered together to review the company's decade-long journey of endeavor and look...
